Scott L. Klakamp

Person

Fremont, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies directed to the deletion mutants of epidermal growth fac...
- Patent number 11,492,411
- Issue date Nov 8, 2022
- Amgen Fremont Inc.
- Richard F. Weber
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Antibodies directed to the deletion mutants of epidermal growth fac...
- Patent number 10,508,153
- Issue date Dec 17, 2019
- Amgen Fremont Inc.
- Richard F. Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to the deletion mutants of epidermal growth fac...
- Patent number 10,118,968
- Issue date Nov 6, 2018
- Amgen Fremont Inc.
- Richard Weber
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed to the deletion mutants of epidermal growth fac...
- Patent number 9,096,672
- Issue date Aug 4, 2015
- Amgen Fremont Inc.
- Richard Weber
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Antibodies directed to the deletion mutants of epidermal growth fac...
- Patent number 9,085,624
- Issue date Jul 21, 2015
- Amgen Fremont Inc.
- Richard Weber
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Antibodies directed to the deletion mutants of epidermal growth fac...
- Patent number 9,073,998
- Issue date Jul 7, 2015
- Amgen Fremont Inc.
- Richard Weber
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Antibodies directed to the deletion mutants of epidermal growth fac...
- Patent number 9,062,113
- Issue date Jun 23, 2015
- Amgen Fremont Inc.
- Richard Weber
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Antibodies directed to GPNMB and uses thereof
- Patent number 8,846,873
- Issue date Sep 30, 2014
- Celldex Therapeutics, Inc.
- Feng Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to tumor necrosis factor and uses thereof
- Patent number 8,101,178
- Issue date Jan 24, 2012
- Amgen Fremont Inc.
- John S. Babcook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fully human monoclonal antibodies to IL-13
- Patent number 7,994,302
- Issue date Aug 9, 2011
- Amgen Inc.
- Ian Foltz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against interleukin-1 β
- Patent number 7,964,193
- Issue date Jun 21, 2011
- Amgen Fremont Inc.
- Larry Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to the deletion mutants of epidermal growth fac...
- Patent number 7,736,644
- Issue date Jun 15, 2010
- Amgen Fremont Inc.
- Richard Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to the deletion mutants of epidermal growth fac...
- Patent number 7,628,986
- Issue date Dec 8, 2009
- Amgen Fremont Inc.
- Richard Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fully human monoclonal antibodies to IL-13
- Patent number 7,585,500
- Issue date Sep 8, 2009
- Amgen Inc.
- Ian Foltz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against interleukin-1β
- Patent number 7,566,772
- Issue date Jul 28, 2009
- Amgen Fremont Inc.
- Larry Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed to tumor necrosis factor
- Patent number 7,285,269
- Issue date Oct 23, 2007
- Amgen Fremont, Inc.
- John S. Babcook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FAC...
- Publication number 20200062860
- Publication date Feb 27, 2020
- Amgen Fremont Inc.
- Richard F. Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed To GPNMB And Uses Thereof
- Publication number 20160311919
- Publication date Oct 27, 2016
- CELLDEX THERAPEUTICS, INC.
- Feng Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FAC...
- Publication number 20150315288
- Publication date Nov 5, 2015
- Amgen Fremont Inc.
- Richard F. Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed to GPNMB and Uses Thereof
- Publication number 20150044212
- Publication date Feb 12, 2015
- CELLDEX THERAPEUTICS, INC.
- Feng Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed To GPNMB And Uses Thereof
- Publication number 20130022597
- Publication date Jan 24, 2013
- Feng Xiao
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies against interleukin-1 beta
- Publication number 20100183616
- Publication date Jul 22, 2010
- Amgen Fremont Inc.
- Larry Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FAC...
- Publication number 20100111979
- Publication date May 6, 2010
- Amgen Fremont Inc.
- Richard Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FULLY HUMAN MONOCLONAL ANTIBODIES TO IL-13
- Publication number 20100047253
- Publication date Feb 25, 2010
- Amgen Inc.
- Ian Foltz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FAC...
- Publication number 20090240038
- Publication date Sep 24, 2009
- Amgen Fremont Inc.
- Richard Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FAC...
- Publication number 20090175887
- Publication date Jul 9, 2009
- Amgen Fremont Inc.
- Richard Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FAC...
- Publication number 20090156790
- Publication date Jun 18, 2009
- Amgen Fremont Inc.
- Richard Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FAC...
- Publication number 20090155282
- Publication date Jun 18, 2009
- Amgen Fremont Inc.
- Richard Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED TO TUMOR NECROSIS FACTOR AND USES THEREOF
- Publication number 20080187531
- Publication date Aug 7, 2008
- John S. Babcook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies against interleukin-1 beta
- Publication number 20070065439
- Publication date Mar 22, 2007
- Larry Green
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fully human monoclonal antibodies to IL-13
- Publication number 20060140948
- Publication date Jun 29, 2006
- Ian Foltz
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies directed to the deletion mutants of epidermal growth fac...
- Publication number 20050059087
- Publication date Mar 17, 2005
- Richard Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies directed to the deletion mutants of epidermal growth fac...
- Publication number 20050053608
- Publication date Mar 10, 2005
- Richard Weber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies directed to tumor necrosis factor and uses thereof
- Publication number 20050049402
- Publication date Mar 3, 2005
- John S. Babcook
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Scott L. Klakamp

Person

Patents Grantslast 30 patents

Antibodies directed to the deletion mutants of epidermal growth fac...

Antibodies directed to the deletion mutants of epidermal growth fac...

Antibodies directed to the deletion mutants of epidermal growth fac...

Antibodies directed to the deletion mutants of epidermal growth fac...

Antibodies directed to the deletion mutants of epidermal growth fac...

Antibodies directed to the deletion mutants of epidermal growth fac...

Antibodies directed to the deletion mutants of epidermal growth fac...

Antibodies directed to GPNMB and uses thereof

Antibodies directed to tumor necrosis factor and uses thereof

Fully human monoclonal antibodies to IL-13

Antibodies against interleukin-1 β

Antibodies directed to the deletion mutants of epidermal growth fac...

Antibodies directed to the deletion mutants of epidermal growth fac...

Fully human monoclonal antibodies to IL-13

Antibodies against interleukin-1β

Antibodies directed to tumor necrosis factor

Patents Applicationslast 30 patents

ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FAC...

Antibodies Directed To GPNMB And Uses Thereof

ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FAC...

Antibodies Directed to GPNMB and Uses Thereof

Antibodies Directed To GPNMB And Uses Thereof

Antibodies against interleukin-1 beta

ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FAC...

FULLY HUMAN MONOCLONAL ANTIBODIES TO IL-13

ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FAC...

ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FAC...

ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FAC...

ANTIBODIES DIRECTED TO THE DELETION MUTANTS OF EPIDERMAL GROWTH FAC...

ANTIBODIES DIRECTED TO TUMOR NECROSIS FACTOR AND USES THEREOF

Antibodies against interleukin-1 beta

Fully human monoclonal antibodies to IL-13

Antibodies directed to the deletion mutants of epidermal growth fac...

Antibodies directed to the deletion mutants of epidermal growth fac...

Antibodies directed to tumor necrosis factor and uses thereof